Biocept Prices Public Offering of Stock and Warrants, Expects $10M in Proceeds – GenomeWeb

GenomeWeb
The company has granted the offering’s underwriters a 45-day overallotment option to purchase up to 1.2 million additional shares of common stock and/or 1.2 million additional warrants. Aegis Capital and Feltl are the joint book-running managers for
Biocept (BIOC) Stock Plummets Today After Pricing Public Offering, WarrantsTheStreet.com
Unusual 11 Mid-Day Movers 2/10: (ANTH) (AMKR) (PFNX) Higher; (BIOC StreetInsider.com
Stocks to Keep Your Eyes on-Biocept (BIOC), Lucas (LEI), Energy (EXXI), Basic Techsonian (press release)
Wall Street Observer
all 7 news articles

…read more

Scroll to Top